Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, Norgren N, Linder J, Forsgren L, Constantinescu R, Zetterberg H, Blennow K, Swedish BioFINDER study. · 2017
Read Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder. by Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, Norgren N, Linder J, Forsgren L, Constantinescu R, Zetterberg H, Blennow K, Swedish BioFINDER study. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5333515.txt.
Description
Oskar Hansson and co-authors tested a blood marker for look-alike brain diseases in Neurology in 2017. Parkinson's disease can be hard to tell from rarer kin disorders early on. A protein called neurofilament light chain, or NfL, leaks from hurt nerve fibers. Its level in spine fluid splits the two groups well, but a spine tap is a hard test to run.
The team used a super-sensitive blood test in three patient groups from Lund, London, and an early disease set. Blood and spine fluid levels of the protein tracked each other closely. Blood levels ran high in all three atypical disorders and stayed low in Parkinson's and in healthy people. The blood test split the groups with strong accuracy in each set, even in the first three years of illness. A simple blood draw may join the workup for these patients.
Catalog record
| CREATOR | Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, Norgren N, Linder J, Forsgren L, Constantinescu R, Zetterberg H, Blennow K, Swedish BioFINDER study. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |